Stocktoria

Akebia Therapeutics, Inc. AKBA

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2014-03-20 · LEI

Akebia Therapeutics, Inc. statistics & valuation

Market cap$305.8M
P / S1.3×
P / B9.4×
P / FCF4.5×
Net margin-2.3%
Return on equity-16.4%
FCF margin28.7%
Net cash$136.6M
Net debt / EBITDA-5.5×
Enterprise value USD$169.2M
EV / EBITDA6.8×
Earnings yield EBIT/EV13.9%
Return on capital11%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Net margin (%)
-8843.50% -40.70% -69.10% -83.50% -129.90% -132.00% -32.20% -26.70% -43.30% -2.30% 2016201720182019202020212022202320242025
Gross margin (%)
2016201720182019202020212022202320242025
Operating margin (%)
-8889.90% -42.30% -85.80% -85.50% -127.50% -124.20% -27.60% -23.80% -31.50% 9.90% 2016201720182019202020212022202320242025
Return on equity (%)
-199.30% -60.10% -22.60% -70.80% -154.90% -381.10% -1801.60% -16.40% 2016201720182019202020212022202320242025
Shares outstanding
38.6M 47.6M 116.9M 121.7M 148.1M 177.0M 184.1M 194.6M 224.8M 265.4M 2016201720182019202020212022202320242025
Net debt ($)
-$71.6M -$132.3M -$52.3M -$24.4M -$8.2M -$13.2M -$136.6M 2016201720182019202020212022202320242025
Share buybacks ($)
2016201720182019202020212022202320242025
Return on assets (%)
-45.20% -20.20% -14.40% -36.30% -59.50% -53.70% -26.50% -21.50% -31.50% -1.40% 2016201720182019202020212022202320242025
Free cash flow margin (%)
3599.00% -31.90% -47.70% -78.80% -37.50% -118.50% -25.10% -12.00% -25.40% 28.70% 2016201720182019202020212022202320242025
Debt / equity (×)
0.19× 0.39× 1.32× 12.63× 1.48× 2016201720182019202020212022202320242025
EPS ($)
-$2.36 -$2.77 -$1.70 -$0.52 -$0.28 -$0.33 -$0.02 2016201720182019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Operating margin9.9%-31.5%-23.8%-27.6%-124.2%-127.5%-85.5%-85.8%-42.3%-8889.9%
Net margin-2.3%-43.3%-26.7%-32.2%-132.0%-129.9%-83.5%-69.1%-40.7%-8843.5%
FCF margin28.7%-25.4%-12.0%-25.1%-118.5%-37.5%-78.8%-47.7%-31.9%3599.0%
Return on assets-1.4%-31.5%-21.5%-26.5%-53.7%-59.5%-36.3%-14.4%-20.2%-45.2%
Return on equity-16.4%141.1%169.8%-1801.6%-381.1%-154.9%-70.8%-22.6%-60.1%-199.3%
Debt / equity1.48×-0.79×-1.13×12.63×1.32×0.39×0.19×———
Current ratio1.551.411.181.431.061.981.491.762.542.59

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.